These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29134461)

  • 1. High-Throughput Process Development for Biopharmaceuticals.
    Shukla AA; Rameez S; Wolfe LS; Oien N
    Adv Biochem Eng Biotechnol; 2018; 165():401-441. PubMed ID: 29134461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput screening of particle conditioning operations: I. System design and method development.
    Noyes A; Huffman B; Godavarti R; Titchener-Hooker N; Coffman J; Sunasara K; Mukhopadhyay T
    Biotechnol Bioeng; 2015 Aug; 112(8):1554-67. PubMed ID: 25728932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes.
    Manahan M; Nelson M; Cacciatore JJ; Weng J; Xu S; Pollard J
    Biotechnol Prog; 2019 Nov; 35(6):e2870. PubMed ID: 31207168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro total analysis systems in biopharmaceutical process development.
    Chen X
    Bioanalysis; 2009 Oct; 1(7):1183-6. PubMed ID: 21083042
    [No Abstract]   [Full Text] [Related]  

  • 5. High-Throughput Process Development for the Chromatographic Purification of Viral Antigens.
    Jacob SI; Konstantinidis S; Bracewell DG
    Methods Mol Biol; 2021; 2183():119-182. PubMed ID: 32959244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative high throughput analytics to support polysaccharide production process development.
    Noyes A; Godavarti R; Titchener-Hooker N; Coffman J; Mukhopadhyay T
    Vaccine; 2014 May; 32(24):2819-28. PubMed ID: 24576849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streamlining process characterization efforts using the high throughput ambr® crossflow system for ultrafiltration and diafiltration processing of monoclonal antibodies.
    Fernandez-Cerezo L; Benner SW; Pollard JM
    Biotechnol Prog; 2021 May; 37(3):e3118. PubMed ID: 33369289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conference scene: recent advancements in microscale bioprocess development.
    Guy H
    Immunotherapy; 2012 Feb; 4(2):145-7. PubMed ID: 22339457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
    Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
    Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-throughput automated platform for the development of manufacturing cell lines for protein therapeutics.
    Shi S; Condon RG; Deng L; Saunders J; Hung F; Tsao YS; Liu Z
    J Vis Exp; 2011 Sep; (55):. PubMed ID: 21968840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The state of biopharmaceutical manufacturing.
    Molowa DT; Mazanet R
    Biotechnol Annu Rev; 2003; 9():285-302. PubMed ID: 14650933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput chromatography and analytics can inform viral clearance capabilities during downstream process development for biologics.
    Gulla KC; Schneiderman ZJ; O'Connell SE; Arias GF; Cibelli NL; Cetlin D; Gowetski DB
    Biotechnol J; 2021 Sep; 16(9):e2000641. PubMed ID: 34174016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization of biopharmaceuticals.
    Parr MK; Montacir O; Montacir H
    J Pharm Biomed Anal; 2016 Oct; 130():366-389. PubMed ID: 27324698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of Raman Spectroscopy in Biopharmaceutical Manufacturing: A Short Review.
    Buckley K; Ryder AG
    Appl Spectrosc; 2017 Jun; 71(6):1085-1116. PubMed ID: 28534676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput miniaturized bioreactors for cell culture process development: reproducibility, scalability, and control.
    Rameez S; Mostafa SS; Miller C; Shukla AA
    Biotechnol Prog; 2014; 30(3):718-27. PubMed ID: 24449637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH measurement and a rational and practical pH control strategy for high throughput cell culture system.
    Zhou H; Purdie J; Wang T; Ouyang A
    Biotechnol Prog; 2010; 26(3):872-80. PubMed ID: 20039376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes.
    Evans ST; Stewart KD; Afdahl C; Patel R; Newell KJ
    J Chromatogr A; 2017 Jul; 1506():73-81. PubMed ID: 28551021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.